The adenine nucleotide translocase 2, a mitochondrial target for anticancer biotherapy

Current Drug Targets

Volumn 12, Issue 6, 2011, Pages 894-901

  Sharaf el dein, Ossama ^a   Mayola, Eléonore ^a   Chopineau, Joël ^b   Brenner, Catherine ^a  

^a Universite Paris Sud   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

Apoptosis; Bcl 2; Chemotherapy; Liposome; Mitochondrion; Oncogene

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CELL SURFACE RECEPTOR; DEATH RECEPTOR; LONIDAMINE; MATRIX METALLOPROTEINASE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL PERMEABILIZATION; CROSS LINKING; HOMEOSTASIS; LUNG NON SMALL CELL CANCER; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 79955592332     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945011795529047     Document Type: Review

References (56)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
2. Reed JC. Apoptosis-based therapies. Nat Rev Drug Discov 2002; 1: 111-21.
3. Lazebnik Y. What are the hallmarks of cancer? Nat Rev Cancer 2010; 10: 232-3.
4. Brenner C, Kroemer G. Apoptosis. Mitochondria--the death signal integrators. Science 2000; 289: 1150-1.
5. Kroemer G, Reed J. Mitochondrial control of cell death. Nat Med 2000; 6: 513-9.
6. Marzo I, Brenner C, Zamzami N, et al. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med 1998a; 187: 1261-71.
7. Marzo I, Brenner C, Zamzami N, et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science 1998; 281: 2027-31.
8. Verrier F, Deniaud A, LeBras M, et al. Dynamic evolution of the adenine nucleotide translocase interactome during chemotherapyinduced apoptosis. Oncogene 2004; 23: 8049-64.
9. Belzacq AS, Vieira HL, Verrier F, et al. Bcl-2 and Bax modulate adenine nucleotide translocase activity. Cancer Res 2003; 63: 541-6.
10. Mullauer F, Kessler J, Medema J. Betulinic acid induces cytochrome c release and apoptosis in a Bax/Bak-independent, permeability transition pore dependent fashion. Apoptosis 2009 14: 191-202.
11. Chevrollier A, Loiseau D, Chabi B, et al. ANT2 isoform required for cancer cell glycolysis. J Bioenerg Biomembr 2005a; 37: 307-16.
12. Pastorino JG, Tafani M, Rothman RJ, Marcineviciute A, Hoek JB, Farber JL. Functional consequences of the sustained or transient activation by Bax of the mitochondrial permeability transition pore. J Biol Chem 1999; 274: 31734-31739.
13. Block MR, Lauquin GJ, Vignais PV. Differential inactivation of atractyloside and bongkrekic acid binding sites on the adenine nucleotide carrier by ultraviolet light: its implication for the carrier mechanism. FEBS Lett 1979; 104: 425-30.
14. Costantini P, Belzacq AS, Vieira HL, et al. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene 2000a; 19: 307-14.
15. Vieira HL, Belzacq AS, Haouzi D, et al. The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 2001; 20: 4305-16.
16. Borgne-Sanchez A, Dupont S, Langonné A, et al. Targeted Vprderived Peptides Reach Mitochondria to Induce Apoptosis of aVb3-Expressing Endothelial Cells. Cell Death Differ 2006; 14: 422-35.
17. Jacotot E, Ferri KF, El Hamel C, et al. Control of Mitochondrial Membrane Permeabilization by Adenine Nucleotide Translocator Interacting with HIV-1 Viral Protein R and Bcl-2. J Exp Med 2001; 193: 509-520.
18. Jan G, Belzacq AS, Haouzi D, et al. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ 2002; 9: 179-88.
19. Brenner C, Kniep B, Maillier E, et al. GD3-7-aldehyde is an apoptosis inducer and interacts with adenine nucleotide translocase. Biochem Biophys Res Commun 2010; 391: 248-53.
20. Belzacq AS, Jacotot E, Vieira HL, et al. Apoptosis induction by the photosensitizer verteporfin: identification of mitochondrial adenine nucleotide translocator as a critical target. Cancer Res 2001; 61: 1260-4.
21. Belzacq AS, El Hamel C, Vieira HL, et al. Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437. Oncogene 2001; 20: 7579-87.
22. Weaver JG, Tarze A, Moffat TC, et al. Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor. J Clin Invest 2005; 115: 1828-38.
23. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 1322-6.
24. Amadori D, Frassineti G, De Matteis A, et al. Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: results from a multicenter prospective randomized trial. Breast Cancer Res Treat 1998; 49: 209-17.
25. Dogliotti L, Danese S, Berruti A, et al. Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study. Cancer Chemother Pharmacol 1998: 333-8.
26. Le Bras M, Borgne-Sanchez A, Touat Z, et al. Chemosensitization by knock-down of adenine nucleotide translocase-2. Cancer Res 2006; 66: 9143-52.
27. Oudard S, Poirson F, Miccoli L, et al. Mitochondria-bound hexokinase as target for therapy of malignant gliomas. Int J Cancer 1995; 62: 216-22.
28. Pulselli R, Amadio L, Fanciulli M, Floridi A. Effect of lonidamine on the mitochondrial potential in situ in Ehrlich ascites tumor cells. Anticancer Res 1996; 16: 419-23.
29. Ravagnan L, Marzo I, Costantini P, et al. Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene 1999; 18: 2537-46.
30. Li Y, Fung K, Kwok T, Lee C, Suen Y, Kong S. Mitochondrial targeting drug lonidamine triggered apoptosis in doxorubicinresistant HepG2 cells. Life Sci 2002; 71: 2729-40.
31. Dolce V, Scarcia P, Iacopetta D, Palmieri F. A fourth ADP/ATP carrier isoform in man: identification, bacterial expression, functional characterization and tissue distribution. FEBS Lett 2005; 579: 633-7.
32. Lunardi J, Attardi G. Differential regulation of expression of the multiple ADP/ATP translocase genes in human cells. J Biol Chem 1991; 266: 16534-40.
33. Giraud S, Bonod-Bidaud C, Wesolowski-Louvel M, Stepien G. Expression of human ANT2 gene in highly proliferative cells: GRBOX, a new transcriptional element, is involved in the regulation of glycolytic ATP import into mitochondria. J Mol Biol 1998; 281: 409-18.
34. Chevrollier A, Loiseau D, Gautier F, Malthiery Y, Stepien G. ANT2 expression under hypoxic conditions produces opposite cellcycle behavior in 143B and HepG2 cancer cells. Mol Carcinog 2005b; 42: 1-8.
35. Bauer MK, Schubert A, Rocks O, Grimm S. Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J Cell Biol 1999; 147: 1493-502.
36. Jang J, Choi Y, Jeon Y, Kim C. Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo. Breast Cancer Res 2008; 10: R11.
37. Decaudin D, Marzo I, Brenner C, Kroemer G. Mitochondria in chemotherapy-induced apoptosis: A prospective novel target of cancer therapy (Review). Int J Oncol 1998; 12: 141-52.
38. Brenner C, Cadiou H, Vieira HL, et al. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 2000; 19: 329-36.
39. Zamzami N, El Hamel C, Maisse C, et al. Bid acts on the permeability transition pore complex to induce apoptosis. Oncogene 2000; 19: 6342-50.
40. Vieira HL, Boya P, Cohen I, et al. Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-X(L). Oncogene 2002; 21: 1963-77.
41. Qi X, Cai Y, Gong L, et al. Role of mitochondrial permeability transition in human renal tubular epithelial cell death induced by aristolochic acid. Toxicol Appl Pharmacol 2007; 222: 105-10.
42. Hwang J, Kuo H, Tseng T, Liu J, Chu C. Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells. Arch Toxicol 2006 80: 62-73.
43. Jantova S, Cipak L, Letasiova S. Berberine induces apoptosis through a mitochondrial/caspase pathway in human promonocytic U937 cells. Toxicol In vitro 2007; 21: 25-31.
44. Pereira C, Machado N, Oliveira P. Mechanisms of berberine (natural yellow 18)-induced mitochondrial dysfunction: interaction with the adenine nucleotide translocator. Toxicol Sci 2008 105: 408-17.
45. Hong J, Samudio I, Chintharlapalli S, Safe S. 1,1-bis(3'-indolyl)-1-(p-substituted phenyl)methanes decrease mitochondrial membrane potential and induce apoptosis in endometrial and other cancer cell lines. Mol Carcinog 2008; 47: 492-507.
46. Bouaziz C, Sharaf El Dein O, El Golli E, et al. Different apoptotic pathways induced by zearalenone, T-2 toxin and ochratoxin A in human hepatoma cells. Toxicology 2008; 254: 19-28.
47. Bouaziz C, Martel C, Sharaf el dein O, et al. Fusarial toxin-induced toxicity in cultured cells and in isolated mitochondria involves PTPC-dependent activation of the mitochondrial pathway of apoptosis. Toxicol Sci 2009; 110: 363-75.
48. Sabbah E, Druillennec S, Morellet N, Bouaziz S, Kroemer G, Roques B. Interaction between the HIV-1 Protein Vpr and the Adenine Nucleotide Translocator. Chem Biol Drug Des 2006: 145-54.
49. Larochette N, Decaudin D, Jacotot E, et al. Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore. Exp Cell Res 1999; 249: 413-21.
50. Lehenkari P, Kellinsalmi M, Näpänkangas J, et al. Further insight into mechanism of action of clodronate: inhibition of mitochondrial ADP/ATP translocase by a nonhydrolyzable, adenine-containing metabolite. Mol Pharmacol 2002; 61: 1255-62.
51. Coleman R. Bisphosphonates in breast cancer. Ann Oncol 2005; 16: 687-95.
52. Michaelson M, Smith M. Bisphosphonates for treatment and prevention of bone metastases. J Clin Oncol 2005; 23: 8219-24.
53. Sabry N, Habib E. Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study. Med Oncol 2010; in press.
54. Dilda P, Ramsay E, Corti A, Pompella A, Hogg P. Metabolism of the tumor angiogenesis inhibitor 4-(N-(S-Glutathionylacetyl) amino)phenylarsonous acid. J Biol Chem 2008; 283: 35428-34.
55. Dilda P, Don A, Tanabe K, et al. Mechanism of selectivity of an angiogenesis inhibitor from screening a genome-wide set of Saccharomyces cerevisiae deletion strains. J Natl Cancer Inst 2005; 97: 1539-47.
56. Oudard S, Carpentier A, Banu E, et al. Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme. J Neurooncol 2003; 63: 81-6.